Skip to main content

Advertisement

SpringerLink
Log in

Gabapentin for Disruptive Behaviour in an Elderly Demented Patient

  • Correspondence
  • Published:
Drugs & Aging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Zimmer JG, Watson N, Treat A. Behavioral problems among patients at skilled nursing facilities. Am J Public Health 1984; 74: 1118–20

    Article  PubMed  CAS  Google Scholar 

  2. Schneider LS, Pollock VE, Lyness SA. A metaanalysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc 1990; 38: 553–63

    PubMed  CAS  Google Scholar 

  3. Tairot PN, Erb R, Leibovici A, et al. Carbamazepine treatment of agitation in nursing home patients with dementia: a preliminary study. J Am Geriatr Soc 1994; 42: 1160–6

    Google Scholar 

  4. Mellow A, Solano-Lopez C, Davis S. Sodium valproate in the treatment of behavioral disturbances in dementia. J Geriatr Psychiatry Neurology 1993; 6: 205–9

    CAS  Google Scholar 

  5. Sandborn W, Bendfeld F, Hamdy R. Valproic acid for physically aggressive behavior in geriatric patients. Am J Geriatr Psychiatry 1995; 3: 239–42

    Article  Google Scholar 

  6. Ryback R, Ryback L. Gabapentin for behavioral dyscontrol agitation [letter]. Am J Psychiatry 1995; 152: 1399

    PubMed  CAS  Google Scholar 

  7. Regan W, Gordon S. Gabapentin for behavioral agitation in Alzheimer’s disease [letter]. J Clin Psychopharmacol 1997; 17: 59–60

    Article  PubMed  CAS  Google Scholar 

  8. Taylor C. Emerging perspectives on the mechanism of action of gabapentin. Neurology 1994; 44 Suppl. 5: S10–6

    PubMed  CAS  Google Scholar 

  9. Ramsay R. Clinical efficacy and safety of gabapentin. Neurology 1994; 44 Suppl. 5: S23–30

    PubMed  CAS  Google Scholar 

  10. Mclean M. Clinical pharmacokinetics of gabapentin. Neurology 1994; 44 Suppl. 5: S17–22

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Parker Jewish Institute for Health Care and Rehabilitation, New Hyde Park, NewYork, USA

    Gregory Goldenberg MD, Kenneth Kahaner MD, Nerlige Basavaraju MD & Srinivas Rangu MD

Authors
  1. Gregory Goldenberg MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenneth Kahaner MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nerlige Basavaraju MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Srinivas Rangu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goldenberg, G., Kahaner, K., Basavaraju, N. et al. Gabapentin for Disruptive Behaviour in an Elderly Demented Patient. Drugs & Aging 13, 183–184 (1998). https://doi.org/10.2165/00002512-199813020-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199813020-00011

Keywords

Search

Navigation